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John J. Ricotta, Ali Aburahma, Enrico Ascher, Mark Eskandari, Peter Faries,
Brajesh K. Lal
Abstract: Management of carotid bifurcation stenosis is a cornerstone of
stroke prevention, and has been the subject of extensive clinical investiga-
tion, including multiple controlled randomized trials. The appropriate treat-
ment of patients with carotid bifurcation disease is of major interest to the
community of vascular surgeons. In 2008 the Society for Vascular Surgery
published guidelines for treatment of carotid artery disease. At the time
only one randomized trial, comparing carotid endarterectomy and carotid
stenting had been published. Since that publication, 4 major randomized
trials comparing carotid endarterectomy and carotid stenting have been
published, and the role of medical management has been reemphasized.
The current publication updates and expands the 2008 guidelines with
specific emphasis on 6 areas: imaging in identification and characterization
of carotid stenosis, medical therapy (both as stand alone management and
in conjunction with intervention in patients with carotid bifurcation
stenosis), risk stratification to select patients for appropriate interventional
management (CEA or CAS), technical standards for performing CEA and CAS,
the relative roles of CEA and CAS and management of unusual conditions
associated with extracranial carotid pathology. Recommendations are
made using the GRADE system, as has been done with other SVS guideline
documents. In contrast to the multispecialty guidelines recently published,
the committee recommends carotid endarterectomy (CEA)vas first line
treatment for most symptomatic patients with stenosis 50-99% and asymp-
tomatic patients with stenosis 60-99%. The perioperative risk of stroke and
death in asymptomatic patients must be below 3% to ensure benefit for
the patient. Carotid Angioplasty and Stent (CAS) should be reserved for
symptomatic patients with stenosis 50-99% at high risk for CEA for anatomic
or medical reasons. CAS is not recommended for asymptomatic patients at
this time. Asymptomatic patients at high risk for intervention or with <3
years life expectancy should be considered for medical management as first
line therapy.One year outcomes of the United States regulatory trial of the Endurant
Stent Graft System
Michel S. Makaroun, Michael Tuchek, Doug Massop, John Henretta, Robert
Rhee, Clifford Buckley, Manish Mehta, Sharif Ellozy, for the Endurant US
Pivotal Trial Investigators
Objective: To report the 1-year outcomes of the United States (US) regula-
tory trial of the Endurant Stent Graft System (Medtronic Vascular), a new
device for the treatment of abdominal aortic aneurysms (AAA).
Methods: This was a prospective, single arm, multicenter trial conducted at
26 sites in the US. From April 2008 to May 2009, 150 patients with AAA were
treated with the Endurant bifurcated stent graft. The main inclusion* Full articles available online at www.jvascsurg.org
1078e5884/$36.00
doi:10.1016/S1078-5884(11)00468-0criteria were an AAA diameter >5 cm, proximal neck length 10 mm, bilat-
eral iliac fixation length 15 mm, and a neck angulation of 60 degrees. A
clinical events committee (CEC) adjudicated all adverse events except
blood loss, and a core laboratory reviewed all imaging. The primary safety
endpoint was freedom from major adverse events at 30 days, and the
primary effectiveness endpoint was successful aneurysm treatment at 12
months.
Results: One hundred forty-nine patients (99.3%) had a successful stent graft
implant, 83.3% under general anesthesia. One failure was due to inability to
cannulate the contralateral gate. One patient developed a neck rupture
during the procedure, but was still treated successfully. Patients were
predominantly male (91.3%), elderly (mean age, 73.1 years) with significant
comorbidities. Mean estimated blood loss was 185 mL (range, 0-1450 mL),
with blood transfusion required in one patient. Average hospital stay was
2.1 days. At 1 month, the major adverse events rate was only 4% with no
operative mortality. Serious adverse events were recorded in 43 of 150
(28.7%) patients. Cardiac (8.7%), fever (6%), urological (4.7%), pulmonary
(4%), and vascular events (4%) were the most frequent. Through 12 months
of follow up, there were no migrations, ruptures, or conversions. No type I
or III endoleaks were identified during the first year. Fifteen of 129 patients
(11.6%) had endoleaks at 6 months and 13 of 130 (10%) at 1 year, all type II
except for one indeterminate endoleak. One Type II endoleak proved to be
a Type IB on later angiography. Ten aneurysm related reinterventions were
performed during the first year of follow up, mostly for limb thrombosis or
stenosis (5) or for type II endoleak (2). Four of the procedures were endovas-
cular. Aneurysm sac diameter decreased >5 mm at 1 year in 47% of patients
and remained stable in 53%. No sac showed an increase of >5 mm. None of
seven late deaths (range, 90-458 days post-implant) was adjudicated to be
aneurysm related.
Conclusion: Early results of the Endurant pivotal trial are quite encouraging
and suggest a safe and effective new device for the treatment of abdominal
aortic aneurysms.Frequency, risk factors, and management of perigraft seroma after open
abdominal aortic aneurysm repair
Ajith K. Kadakol, Timothy J. Nypaver, Judith C. Lin, Mitchell R. Weaver,
Joseph L. Karam, Daniel J. Reddy, Georges K. Haddad, Alexander D. Shepard
Objective: Perigraft seroma (PGS) causing enlargement of the native aneu-
rysm sac after open abdominal aortoiliac aneurysm (AAA) repair is a rarely
recognized complication with unknown clinical consequences. This study
was undertaken to determine the frequency of PGS, identify associated
risk factors, and review resulting complications and their management
strategies.
Methods: Charts of all patients who underwent open AAA repair at our insti-
tution from 1995 to 2009 and had at least one postoperative abdominal
cross-sectional imaging study (the study subjects) were retrospectively
reviewed. PGS was defined as a perigraft fluid collection present >3 months
postoperatively, 3-cm in diameter and having a radiodensity 25 Houns-
field units on computed tomography (CT). Patient records were reviewed
for demographics, comorbidities, operative and postoperative variables,
and long-term outcome.
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with Dacron grafts and 98 with polytetrafluoroethylene (PTFE) grafts.
Twenty patients (18%) had PGS, all of whom had PTFE grafts (20 of 98;
20.4%). Mean age was 68.5 years and mean aneurysm diameter preopera-
tively was 6.4 cm (range, 4.0-10.9 cm). The average time from AAA repair
to PGS detection was 51 months (range, 4-156 months). PGS averaged 6.0-
cm in diameter (range, 3.0-11.0 cm). Multivariate analysis revealed that
the following factors were associated with PGS development: diabetes
(odds ratio [OR], 3.5; 95% confidence interval [CI], 1.1-21.2; P = .013),
smoking (OR, 5.6; 95% CI, 0.73-33.74; P = .01), anticoagulation (OR, 7.2;
95% CI, 2.6-63.3; P = .003), bifurcated graft reconstruction (OR, 8.0; 95%
CI, 2.6-94.1; P = .017), and left flank retroperitoneal approach for repair
(OR, 7.1; 95% CI, 1.9-26.5; P = .003). Four patients (4 of 20; 20%) required
intervention for PGS-related complications: 3 patients for symptomatic
PGS expansion (1 patient with rupture) and 1 patient for acute limb
ischemia secondary to graft limb compression and thrombosis. Two
patients had open exploration, sac evacuation/reduction, and graft
replacement with a Dacron graft: 1 patient for a ruptured aneurysm sac
and 1 patient for persistent pain associated with sac enlargement. A third
patient underwent a failed CT-guided drainage for abdominal pain and was
subsequently treated with partial graft excision. The patient with acute
limb ischemia was treated with catheter-directed thrombolysis and graft
limb stenting.
Conclusion: PGS after open AAA repair occurs more frequently than previ-
ously reported. Complications requiring intervention can occur in up to
20% of patients with PGS. A variety of treatment modalities can be used to
deal with the complications. Earlier CT surveillance is advised after open
AAA repair with a PTFE graft if symptoms are suggestive of PGS
development.Risk factors, outcomes, and clinical manifestations of spinal cord ischemia
following thoracic endovascular aortic repair
Brant W. Ullery, Albert T. Cheung, Ronald M. Fairman, Benjamin M. Jackson,
Edward Y. Woo, Joseph Bavaria, Alberto Pochettino, Grace J. Wang
Objective: The purpose of this study was to assess the incidence, risk
factors, and clinical manifestations of spinal cord ischemia (SCI) after
thoracic endovascular aortic repair (TEVAR).
Methods: A retrospective review of a prospectively collected database was
performed for all patients undergoing TEVAR at a single academic institution
between July 2002 and June 2010. Preoperative demographics, procedure-
related variables, and clinical details related to SCI were examined. Logistic
regression analysis was performed to identify risk factors for the develop-
ment of SCI.
Results: Of the 424 patients who underwent TEVAR during the study period,
12 patients (2.8%) developed SCI. Mean age of this cohort with SCI was 69.6
years (range, 44-84 years), and 7 were women. One-half of these patients
had prior open or endovascular aortic repair. Indication for surgery was
either degenerative aneurysm (n = 8) or dissection (n = 4). Six TEVARs
were performed electively, with the remaining done either urgently or
emergently due to contained rupture (n = 2), dissection with malperfusion
(n = 2), or severe back pain (n = 2). All 12 patients underwent extent C endo-
vascular coverage. Multivariate regression analysis demonstrated chronic
renal insufficiency to be independently associated with SCI (odds ratio
[OR], 4.39; 95% confidence interval [CI], 1.2-16.6; P = .029). Onset of SCI
occurred at a median of 10.6 hours (range, 0-229 hours) postprocedure
and was delayed in 83% (n = 10) of patients. Clinical manifestations of SCI
included lower extremity paraparesis in 9 patients and paraplegia in 3
patients. At SCI onset, average mean arterial pressure (MAP) and lumbar
cerebrospinal fluid (CSF) pressure was 77 mm Hg and 10 mm Hg, respec-
tively. Therapeutic interventions increased blood pressure to a significantly
higher average MAP of 99 mm Hg (P = .001) and decreased lumbar CSF pres-
sure to a mean of 7 mm Hg (P = .30) at the time of neurologic recovery.
Thirty-day mortality was 8% (1 of 12 patients). The single patient who
expired, never recovered any lower extremity neurologic function. All
patients surviving to discharge experienced either complete (n = 9) or incom-
plete (n = 2) neurologic recovery. At mean follow-up of 49 months, 7 of 9
patients currently alive continued to exhibit complete, sustained neurologic
recovery.
Conclusion: Spinal cord ischemia after TEVAR is an uncommon, but impor-
tant complication. Preoperative renal insufficiency was identified as a risk
factor for the development of SCI. Early detection and treatment of SCI
with blood pressure augmentation alone or in combination with CSF drainagewas effective in most patients, with the majority achieving complete, long-
term neurologic recovery.Long-termresults of openandendovascular revascularizationof superficial
femoral artery occlusive disease
Salvatore T. Scali, Eva M. Rzucidlo, Aja A. Bjerke, David H. Stone, Daniel B.
Walsh, Philip P. Goodney, Catherine K. Chang, Richard J. Powell
Background: First-line treatment for patients with superficial femoral arte-
rial (SFA) occlusive disease has yet to be determined. This study compared
long-term outcomes between primary SFA stent placement and primary
femoral-popliteal bypass. Periprocedural patient factors were examined to
determine their effect on these results.
Methods: All femoral-popliteal bypasses and SFA interventions performed in
consecutive patients with symptoms Rutherford 3 to 6 between 2001 and
2008 were reviewed. Time-dependent outcomes were analyzed using the
Kaplan-Meier method and log-rank test. Cox proportional hazards were per-
formed to determine predictors of graft patency. Multivariate analysis was
completed to identify patient covariates most often associated with the
primary therapy.
Results: A total of 152 limbs in 141 patients (66% male; mean age, 66  22
years) underwent femoral-popliteal bypass, and 233 limbs in 204 patients
(49% male; mean age, 70  11 years) underwent SFA interventions. Four-
year primary, primary-assisted, and secondary patency rates were 69%,
78%, and 83%, respectively, for bypass patients and 66%, 91%, and 95%,
respectively, for SFA interventions. Six-year limb salvage was 80% for bypass
vs 92% for stenting (P = .04). Critical limb ischemia (CLI) and renal insuffi-
ciency were predictors of bypass failure. Claudication was a predictor of
success for SFA stenting. Three-year limb salvage rates for CLI patients
undergoing surgery and SFA stenting were 83%. Amputation-free survival at
3 years for CLI patients was 55% for bypass and 59% for SFA interventions.
Multivariate predictors (odds ratios and 95% confidence intervals) of covari-
ates most frequently associated with first-line SFA stenting were TransAt-
lantic Inter-Society Consensus II A and B lesions (5.9 [3.4-9.1], P < .001),
age >70 years (2.1 [1.4-3.1], P < .001), and claudication (1.7 [1.1-2.7], P
= .01). Regarding bypass as first-line therapy, claudicant patients were
more likely to have nondiabetic status (5.6 [3.3-9.4], P < .001), creatinine
<1.8 mg/dL (4.6 [1.5-14.9], P = .01), age <70 years (2.7 [CI, 1.6-8.3],
P < .001), and presence of an above-knee popliteal artery target vessel
(1.9 [CI, 1.1-3.4] P = .02).
Conclusion: Indication, patient-specific covariates, and anatomic lesion
classification have significant association when determining surgeon selec-
tion of SFA stenting or femoral-popliteal bypass as first-line therapy.
Patients with SFA disease can have comparable long-term results when
treatment options are well matched to patient-specific and anatomic
characteristics.Duplex ultrasound screening detects high rates of deep vein thromboses
in critically ill trauma patients
Amir Azarbal, Susan Rowell, Jason Lewis, Rakhee Urankar, Shannon Moseley,
Gregory Landry, Greg Moneta
Objective: American College of Chest Physician (ACCP) guidelines stratify
deep venous thrombosis (DVT) risk in trauma patients based on injury
pattern and pharmacologic prophylaxis. Screening is only recommended
for patients with high-risk injuries who are unable to receive pharmacologic
prophylaxis. However, the prevalence of lower extremity DVT (LEDVT) in
trauma patients may be higher than reported in previous studies as many
studies on DVT screening have not investigated calf vein DVTs (CVDVT) and
have not exclusively targeted critically ill patients. Given that current
ACCP guidelines recommend treatment of CVDVTs, we investigated the effi-
cacy of duplex ultrasound (DUS) screening in critically ill trauma patients for
all LEDVTs, including CVDVT, regardless of injury pattern, risk factors, or
pharmacologic prophylaxis.
Methods: Medical records of 264 intensive care unit trauma patients who
received DUS screening for LEDVT were retrospectively examined for the
presence of injuries conferring high risk for LEDVT, patient specific DVT
risk factors, and low molecular weight heparin (LMWH) prophylaxis.
Results: Forty (15.2%) patients had LEDVTs found on DUS screening, 24 (60%)
were CVDVT, and 30% of all DVTs were diagnosed within 1 week of admission.
Patients without high-risk injuries receiving LMWH had a 13.5% DVT rate,
Abstracts 407which did not differ significantly from the 19.7% DVT rate in high-risk injury
patients not receiving LMWH (P = .667).
Conclusions: Lower extremity DVT is common in critically ill trauma
patients, particularly in the first week following injury, regardless of injury
pattern, DVT risk factors, or pharmacologic prophylaxis. Previous studies
have underestimated DVT rates by not investigating CVDVTs and not exclu-
sively targeting critically ill patients. We recommend early and continued
DUS DVT screening of all critically ill trauma patients.Hand ischemia associated with elbow trauma in children
Pavan Brahmamdam, Mitchell Plummer, J. Gregory Modrall, Stephen M.
Megison, G. Patrick Clagett, R. James Valentine
Objectives: Previous observational studies suggest that children with hand
ischemia following elbow trauma can be safely observed if Doppler signals
are present in the wrist arteries (pink pulseless hand, PPH). Nonoperative
management of PPH is predicated on the assumption that PPH results from
local arterial spasm, but the mechanism of arterial compromise has not
been investigated. We hypothesized that PPH signifies a brachial artery
injury that requires surgical repair.
Methods: Retrospective review of operations performed on children with
hand ischemia following elbow trauma at a level I trauma center pediatric
hospital.
Results: Between 2003 and 2010, 12 children (seven males, mean age 7.4
years) underwent brachial artery exploration for hand ischemia following
elbow trauma (11 supracondylar fractures, one elbow dislocation) due to falls
(n = 10) or motor vehicle crashes (n = 2). At presentation, three subjects had
normal radial pulses, eight subjects had Doppler signals but no palpable
pulses, and one had weak Doppler flow with advanced hand ischemia. Six of
the nine subjects without palpable pulses also had neurosensory changes.
All 12 subjects underwent brachial artery exploration either initially (n = 2)
or following orthopedic fixation (n = 10) due to persistent pulselessness. At
operation, eight of 12 patients (67%) had focal brachial artery thrombosis
due to intimal flaps, and four had brachial artery and median nerve entrap-
ment within the pinned fracture site. At discharge, all 12 subjects had
palpable radial pulses, but three with entrapment had dense median nerve
deficits. One of the three subjects with dense neurologic deficit had complete
recovery of neurologic function at ten months. The other two subjects had
residual median nerve deficits with partial recovery at 5 and 6 months
follow-up, respectively. No patient developed Volkman’s contracture.
Conclusions: Brachial artery injuries should be anticipated in children with
hand ischemia associated with elbow trauma. Neurovascular entrapment at
the fracture site is a possible complication of orthopedic fixation. Absence ofpalpable wrist pulses after orthopedic fixation should prompt immediate
brachial artery exploration. PPH should not be considered a consequence
of arterial spasm in these patients.Resident and fellow experiences after the introduction of endovascular
aneurysm repair for abdominal aortic aneurysm
Teviah Sachs, Marc Schermerhorn, Frank Pomposelli, Philip Cotterill, James
O’Malley, Bruce Landon
Objectives: This study assessed trends in open and endovascular repair
(EVAR) of intact and ruptured abdominal aortic aneurysm (AAA) in the Medi-
care population and evaluated recent trends in AAA repair at vascular
fellowship training programs.
Methods: We identified all Medicare beneficiaries with a diagnosis of AAA
who underwent repair or had a primary diagnosis of rupture (1995-2008).
Cohorts were compared by type of repair (open vs EVAR) and presentation
(intact vs ruptured AAA). Demographics of age, sex, and race were evalu-
ated. We used unique hospital identifier codes to compare trends and 30-
day mortality between hospitals that participate in vascular surgery fellow-
ship training and those that do not. American Council on Graduate Medical
Education data, only available for the years 1999 to 2008, were further
used to better understand the changes in number of EVAR and open repairs
of AAA performed each year for vascular fellows and general surgery resi-
dents, over time.
Results: We identified 449,122 patients (76% men), with 376,355 intact AAAs
(84%) and 72,767 ruptured AAAs (16%). Mean age was 75.1 years. Use of EVAR
for intact AAA rose to from 35% in 2001 to 63% in 2005 and comprised 78% of
repairs by 2008. During the same period, the number of ruptured AAAs
decreased by 40% overall, with nonoperative ruptured AAAs decreasing by
29% and EVAR increasing to 31% of rupture repairs. Hospitals training
vascular fellows were quicker to adopt EVAR (2-year lag time) for intact
AAA and had higher rates of EVAR for ruptured AAA (41.1% vs 29.2%; P =
.001) than did hospitals without fellows. Mortality rates for open repairs
of intact (4.0% vs 5.0%; P = .01) and ruptured AAA (34.1% vs 41.0%; P =
.031) were lower at fellowship hospitals. The average number of open AAA
repairs performed by vascular fellows dropped 50% (44.1 to 21.6/year)
from 1999 to 2008.
Conclusions: Contrary to the expectation of a plateau, use of EVAR for
intact AAA continues to rise at fellowship and nonfellowship hospitals. Use
of EVAR for rupture is being used more often at fellowship programs. The
decline in open repairs performed by vascular fellows, and at fellowship
and non-fellowship hospitals, may have important implications for future
attending experience.
